메뉴 건너뛰기




Volumn 35, Issue 12, 2011, Pages 813-818

HBV-carriers: When is monitoring and surveillance sufficient? (point of view)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; INTERFERON; NUCLEOSIDE ANALOG; NUCLEOTIDE DERIVATIVE;

EID: 84859512753     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.06.013     Document Type: Short Survey
Times cited : (8)

References (51)
  • 1
    • 70349240414 scopus 로고    scopus 로고
    • Chronic hepatitis B: update 2009
    • Lok, A.S., McMahon, B.J., Chronic hepatitis B: update 2009. Hepatology 50 (2009), 661–662.
    • (2009) Hepatology , vol.50 , pp. 661-662
    • Lok, A.S.1    McMahon, B.J.2
  • 2
    • 51049107683 scopus 로고    scopus 로고
    • Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
    • Liaw, Y.F., Leung, N., Kao, J.H., et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2 (2008), 263–283.
    • (2008) Hepatol Int , vol.2 , pp. 263-283
    • Liaw, Y.F.1    Leung, N.2    Kao, J.H.3
  • 3
    • 58149296156 scopus 로고    scopus 로고
    • EASL clinical practice guidelines: management of chronic hepatitis
    • European Association for the Study of the Liver, EASL clinical practice guidelines: management of chronic hepatitis. J Hepatol 50 (2009), 227–242.
    • (2009) J Hepatol , vol.50 , pp. 227-242
    • European Association for the Study of the Liver1
  • 4
    • 19544391413 scopus 로고    scopus 로고
    • Lamivudine for patients with chronic hepatitis B and advanced liver disease
    • Liaw, Y.F., Sung, J.J., Chow, W.C., et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351 (2004), 1521–1531.
    • (2004) N Engl J Med , vol.351 , pp. 1521-1531
    • Liaw, Y.F.1    Sung, J.J.2    Chow, W.C.3
  • 5
    • 79251496109 scopus 로고    scopus 로고
    • Review article: chronic hepatitis B–anti-viral or immunomodulatory therapy?
    • Rijckborst, V., Sonneveld, M.J., Janssen, H., Review article: chronic hepatitis B–anti-viral or immunomodulatory therapy?. Aliment Pharmacol Ther 33 (2011), 501–513.
    • (2011) Aliment Pharmacol Ther , vol.33 , pp. 501-513
    • Rijckborst, V.1    Sonneveld, M.J.2    Janssen, H.3
  • 6
    • 66149190942 scopus 로고    scopus 로고
    • Side effects of long-term oral antiviral therapy for hepatitis B
    • Fontana, R.J., Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology(5), 2009, S185–S195.
    • (2009) Hepatology , Issue.5 , pp. S185-S195
    • Fontana, R.J.1
  • 7
    • 67649224111 scopus 로고    scopus 로고
    • Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia
    • Liaw, Y.F., Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol 51 (2009), 403–410.
    • (2009) J Hepatol , vol.51 , pp. 403-410
    • Liaw, Y.F.1
  • 8
    • 34247478067 scopus 로고    scopus 로고
    • Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome
    • Andreani, T., Serfaty, L., Mohand, D., et al. Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome. Clin Gastroenterol Hepatol 5 (2007), 636–641.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 636-641
    • Andreani, T.1    Serfaty, L.2    Mohand, D.3
  • 9
    • 42949107039 scopus 로고    scopus 로고
    • Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT
    • Kumar, M., Sarin, S.K., Hissar, S., et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 134 (2008), 1376–1384.
    • (2008) Gastroenterology , vol.134 , pp. 1376-1384
    • Kumar, M.1    Sarin, S.K.2    Hissar, S.3
  • 10
    • 34547488366 scopus 로고    scopus 로고
    • Risk and predictors of mortality associated with chronic hepatitis B infection
    • Iloeje, U.H., Yang, H.I., Jen, C.L., et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol 5 (2007), 921–931.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 921-931
    • Iloeje, U.H.1    Yang, H.I.2    Jen, C.L.3
  • 11
    • 29944436855 scopus 로고    scopus 로고
    • Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
    • Chen, C.J., Yang, H.I., Su, J., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006), 65–73.
    • (2006) JAMA , vol.295 , pp. 65-73
    • Chen, C.J.1    Yang, H.I.2    Su, J.3
  • 12
    • 33644858331 scopus 로고    scopus 로고
    • Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
    • Iloeje, U.H., Yang, H.I., Su, J., et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130 (2006), 678–686.
    • (2006) Gastroenterology , vol.130 , pp. 678-686
    • Iloeje, U.H.1    Yang, H.I.2    Su, J.3
  • 13
    • 79951649293 scopus 로고    scopus 로고
    • Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B
    • Croagh, C.M., Bell, S.J., Slavin, J., et al. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B. Liver Int 30 (2010), 1085–1086.
    • (2010) Liver Int , vol.30 , pp. 1085-1086
    • Croagh, C.M.1    Bell, S.J.2    Slavin, J.3
  • 14
    • 77749308564 scopus 로고    scopus 로고
    • Significant histopathology in Chinese chronic hepatitis B patients with persistently high–normal alanine aminotransferase
    • Gui, H.L., Wang, H., Yang, Y.H., et al. Significant histopathology in Chinese chronic hepatitis B patients with persistently high–normal alanine aminotransferase. J Viral Hepat 17 (2010), 44–50.
    • (2010) J Viral Hepat , vol.17 , pp. 44-50
    • Gui, H.L.1    Wang, H.2    Yang, Y.H.3
  • 15
    • 0021858507 scopus 로고
    • Natural history of chronic hepatitis B virusinfection in Taiwan: studies of hepatitis B virus DNA in serum
    • Chu, C.M., Karayiannis, P., Fowler, M.J.F., et al. Natural history of chronic hepatitis B virusinfection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 5 (1985), 431–434.
    • (1985) Hepatology , vol.5 , pp. 431-434
    • Chu, C.M.1    Karayiannis, P.2    Fowler, M.J.F.3
  • 16
    • 34548303664 scopus 로고    scopus 로고
    • Natural history and disease progression in Chinese chronic hepatitis B patients in immunetolerant phase
    • Hui, C.K., Leung, N., Yuen, S.T., et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immunetolerant phase. Hepatology 46 (2007), 395–401.
    • (2007) Hepatology , vol.46 , pp. 395-401
    • Hui, C.K.1    Leung, N.2    Yuen, S.T.3
  • 17
    • 57249086243 scopus 로고    scopus 로고
    • Need to strictly define hepatitis B virus (HBV) immunotolerant patients to avoid unnecessary liver biopsy
    • Andreani, T., Serfaty, L., Poupon, R., et al. Need to strictly define hepatitis B virus (HBV) immunotolerant patients to avoid unnecessary liver biopsy. Gastroenterology 135 (2008), 2155–2156.
    • (2008) Gastroenterology , vol.135 , pp. 2155-2156
    • Andreani, T.1    Serfaty, L.2    Poupon, R.3
  • 18
    • 67650957714 scopus 로고    scopus 로고
    • Hepatitis B virus immunotolerant patients: need to differentiate patients with or without liver disease
    • Kumar, M., Sarin, S.K., Hepatitis B virus immunotolerant patients: need to differentiate patients with or without liver disease. Gastroenterology 137 (2009), 742–743.
    • (2009) Gastroenterology , vol.137 , pp. 742-743
    • Kumar, M.1    Sarin, S.K.2
  • 19
    • 0037008087 scopus 로고    scopus 로고
    • Updated definitions of healthy ranges for serum alanine aminotransferase levels
    • Prati, D., Taioli, E., Zanella, A., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137 (2002), 1–10.
    • (2002) Ann Intern Med , vol.137 , pp. 1-10
    • Prati, D.1    Taioli, E.2    Zanella, A.3
  • 20
    • 58849110389 scopus 로고    scopus 로고
    • Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients
    • Wong, G.L., Wong, V.W., Choi, P.C., et al. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients. Clin Gastroenterol Hepatol 7 (2009), 227–233.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 227-233
    • Wong, G.L.1    Wong, V.W.2    Choi, P.C.3
  • 21
    • 33846983919 scopus 로고    scopus 로고
    • Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion
    • Chu, C.M., Liaw, Y.F., Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat 14 (2007), 147–152.
    • (2007) J Viral Hepat , vol.14 , pp. 147-152
    • Chu, C.M.1    Liaw, Y.F.2
  • 22
    • 27444441182 scopus 로고    scopus 로고
    • Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
    • Yuen, M.F., Yuan, H.J., Wong, D.K., et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 54 (2005), 1610–1614.
    • (2005) Gut , vol.54 , pp. 1610-1614
    • Yuen, M.F.1    Yuan, H.J.2    Wong, D.K.3
  • 23
    • 67649199520 scopus 로고    scopus 로고
    • Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time
    • Tai, D.I., Lin, S.M., Sheen, I.S., Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. Hepatology 49 (2009), 1859–1867.
    • (2009) Hepatology , vol.49 , pp. 1859-1867
    • Tai, D.I.1    Lin, S.M.2    Sheen, I.S.3
  • 24
    • 56149086622 scopus 로고    scopus 로고
    • Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    • Papatheodoridis, G.V., Manesis, E.K., Manolakopoulos, S., et al. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?. Hepatology 48 (2008), 1451–1459.
    • (2008) Hepatology , vol.48 , pp. 1451-1459
    • Papatheodoridis, G.V.1    Manesis, E.K.2    Manolakopoulos, S.3
  • 25
    • 10744221863 scopus 로고    scopus 로고
    • Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis
    • Myers, R.P., Tainturier, M.H., Ratziu, V., et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis. J Hepatol 39 (2003), 222–230.
    • (2003) J Hepatol , vol.39 , pp. 222-230
    • Myers, R.P.1    Tainturier, M.H.2    Ratziu, V.3
  • 26
    • 84984569437 scopus 로고    scopus 로고
    • Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels
    • Lin, C.L., Liao, L.Y., Liu, C.J., Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels. Hepatology 45 (2007), 1193–1198.
    • (2007) Hepatology , vol.45 , pp. 1193-1198
    • Lin, C.L.1    Liao, L.Y.2    Liu, C.J.3
  • 27
    • 35748984106 scopus 로고    scopus 로고
    • The clinical significance of persistently normal ALT in chronic hepatitis B infection
    • Lai, M., Hyatt, B.J., Nasser, I., Curry, M., Afdhal, N.H., The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 47 (2007), 760–767.
    • (2007) J Hepatol , vol.47 , pp. 760-767
    • Lai, M.1    Hyatt, B.J.2    Nasser, I.3    Curry, M.4    Afdhal, N.H.5
  • 28
    • 42949096013 scopus 로고    scopus 로고
    • Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels
    • Tsang, P.S., Trinh, H., Garcia, R.T., Phan, J.T., Ha, N.B., Nguyen, H., et al. Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. Clin Gastroenterol Hepatol 6 (2008), 569–574.
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 569-574
    • Tsang, P.S.1    Trinh, H.2    Garcia, R.T.3    Phan, J.T.4    Ha, N.B.5    Nguyen, H.6
  • 29
    • 77950609092 scopus 로고    scopus 로고
    • Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage
    • Wu, I.C., Lai, C.L., Han, S.H., Han, K.H., Gordon, S.C., Chao, Y.C., et al. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage. Hepatology 51 (2010), 1185–1189.
    • (2010) Hepatology , vol.51 , pp. 1185-1189
    • Wu, I.C.1    Lai, C.L.2    Han, S.H.3    Han, K.H.4    Gordon, S.C.5    Chao, Y.C.6
  • 30
    • 60349102372 scopus 로고    scopus 로고
    • High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels
    • Park, J.Y., Park, Y.N., Kim, D.Y., et al. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels. J Viral Hepat 15 (2008), 615–621.
    • (2008) J Viral Hepat , vol.15 , pp. 615-621
    • Park, J.Y.1    Park, Y.N.2    Kim, D.Y.3
  • 31
    • 34848825946 scopus 로고    scopus 로고
    • Presence of biopsy-proven histologic damage (necroinflamamtion and fibrosis) is common even when ALT is less than 2 X ULN in patients with chronic hepatitis
    • Terrault, N., Kim, R., Schalm, S., et al. Presence of biopsy-proven histologic damage (necroinflamamtion and fibrosis) is common even when ALT is less than 2 X ULN in patients with chronic hepatitis. J Hepatol, 46(suppl 1), 2007, S184.
    • (2007) J Hepatol , vol.46 , pp. S184
    • Terrault, N.1    Kim, R.2    Schalm, S.3
  • 32
    • 77952742728 scopus 로고    scopus 로고
    • Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B
    • Jeng, W.J., Sheen, I.S., Liaw, Y.F., Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B. Clin Gastroenterol Hepatol 8 (2010), 541–545.
    • (2010) Clin Gastroenterol Hepatol , vol.8 , pp. 541-545
    • Jeng, W.J.1    Sheen, I.S.2    Liaw, Y.F.3
  • 33
    • 0037371501 scopus 로고    scopus 로고
    • A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy
    • Yuen, M.F., Yuan, H.J., Hui, C.K., et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 52 (2003), 416–419.
    • (2003) Gut , vol.52 , pp. 416-419
    • Yuen, M.F.1    Yuan, H.J.2    Hui, C.K.3
  • 34
    • 0023219186 scopus 로고
    • Relation of the hepatitis B virus carrier state to hepatocellular carcinoma
    • Popper, H., Shafritz, D.A., Hoofnagle, J.H., Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 7 (1987), 764–772.
    • (1987) Hepatology , vol.7 , pp. 764-772
    • Popper, H.1    Shafritz, D.A.2    Hoofnagle, J.H.3
  • 35
    • 0036110833 scopus 로고    scopus 로고
    • Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers
    • Martinot-Peignoux, M., Boyer, N., Colombat, M., et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 36 (2002), 543–546.
    • (2002) J Hepatol , vol.36 , pp. 543-546
    • Martinot-Peignoux, M.1    Boyer, N.2    Colombat, M.3
  • 36
    • 55549091704 scopus 로고    scopus 로고
    • The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study
    • Zacharakis, G., Koskinas, J., Kotsiou, S., et al. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study. J Hepatol 49 (2008), 884–891.
    • (2008) J Hepatol , vol.49 , pp. 884-891
    • Zacharakis, G.1    Koskinas, J.2    Kotsiou, S.3
  • 37
    • 77950609492 scopus 로고    scopus 로고
    • Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?
    • Lok, A., Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?. Hepatology, 51, 2010, 1109.
    • (2010) Hepatology , vol.51 , pp. 1109
    • Lok, A.1
  • 38
    • 0036614299 scopus 로고    scopus 로고
    • Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
    • Hsu, Y.S., Chien, R.N., Yeh, C.T., et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35 (2002), 1522–1527.
    • (2002) Hepatology , vol.35 , pp. 1522-1527
    • Hsu, Y.S.1    Chien, R.N.2    Yeh, C.T.3
  • 39
    • 77951670101 scopus 로고    scopus 로고
    • Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death
    • Chen, J.D., Yang, H.I., Iloeje, U.H., et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 138 (2010), 1747–1754.
    • (2010) Gastroenterology , vol.138 , pp. 1747-1754
    • Chen, J.D.1    Yang, H.I.2    Iloeje, U.H.3
  • 40
    • 73149100612 scopus 로고    scopus 로고
    • Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study
    • Dutta, A., Saha, C., Johnson, C.S., et al. Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study. Hepatology 50 (2009), 1957–1962.
    • (2009) Hepatology , vol.50 , pp. 1957-1962
    • Dutta, A.1    Saha, C.2    Johnson, C.S.3
  • 41
    • 77951483260 scopus 로고    scopus 로고
    • Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology
    • Lee, J.K., Shim, J.H., Lee, H.C., et al. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology 51 (2010), 1577–1583.
    • (2010) Hepatology , vol.51 , pp. 1577-1583
    • Lee, J.K.1    Shim, J.H.2    Lee, H.C.3
  • 42
    • 33847701354 scopus 로고    scopus 로고
    • Chronic hepatitis B
    • Lok, A.S.F., McMahon, B.J., Chronic hepatitis B. Hepatology 45 (2007), 507–539.
    • (2007) Hepatology , vol.45 , pp. 507-539
    • Lok, A.S.F.1    McMahon, B.J.2
  • 43
    • 34548316975 scopus 로고    scopus 로고
    • Serum hepatitis B virus-DNA cut-off levels in hepatitis B e antigen-negative chronic hepatitis B virus infection
    • Papatheodoridis, G.V., Manesis, E.K., Manolakopoulos, S., et al. Serum hepatitis B virus-DNA cut-off levels in hepatitis B e antigen-negative chronic hepatitis B virus infection. Hepatology 46 (2007), 606–607.
    • (2007) Hepatology , vol.46 , pp. 606-607
    • Papatheodoridis, G.V.1    Manesis, E.K.2    Manolakopoulos, S.3
  • 44
    • 77952745777 scopus 로고    scopus 로고
    • Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase
    • Chu, C.M., Chen, Y.C., Tai, D.I., et al. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase. Clin Gastroenterol Hepatol 8 (2010), 535–540.
    • (2010) Clin Gastroenterol Hepatol , vol.8 , pp. 535-540
    • Chu, C.M.1    Chen, Y.C.2    Tai, D.I.3
  • 45
    • 61949446214 scopus 로고    scopus 로고
    • Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL
    • Dai, C.Y., Chuang, W.L., Huang, J.F., et al. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL. Hepatology 49 (2009), 704–705.
    • (2009) Hepatology , vol.49 , pp. 704-705
    • Dai, C.Y.1    Chuang, W.L.2    Huang, J.F.3
  • 46
    • 36349010112 scopus 로고    scopus 로고
    • Hepatitis B virus DNA prediction rules for hepatitis B e antigen negative chronic hepatitis B
    • Feld, J.J., Ayers, M., El-Ashry, D., et al. Hepatitis B virus DNA prediction rules for hepatitis B e antigen negative chronic hepatitis B. Hepatology 46 (2007), 1057–1070.
    • (2007) Hepatology , vol.46 , pp. 1057-1070
    • Feld, J.J.1    Ayers, M.2    El-Ashry, D.3
  • 47
    • 77955494346 scopus 로고    scopus 로고
    • Use of hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers
    • Brunetto, M.R., Olivari, F., Colombatto, P., et al. Use of hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 139 (2010), 483–490.
    • (2010) Gastroenterology , vol.139 , pp. 483-490
    • Brunetto, M.R.1    Olivari, F.2    Colombatto, P.3
  • 48
    • 79959622830 scopus 로고    scopus 로고
    • Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels
    • Nakazawa, T., Shibuya, A., Takeuchi, A., et al. Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels. J Viral Hepat, 2011, 10.1111/j.1365-2893.2010.01427.x.
    • (2011) J Viral Hepat
    • Nakazawa, T.1    Shibuya, A.2    Takeuchi, A.3
  • 49
    • 54449096612 scopus 로고    scopus 로고
    • Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States
    • Tong, M.J., Hsien, C., Hsu, L., et al. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States. Hepatology 48 (2008), 1070–1078.
    • (2008) Hepatology , vol.48 , pp. 1070-1078
    • Tong, M.J.1    Hsien, C.2    Hsu, L.3
  • 50
    • 78751548591 scopus 로고    scopus 로고
    • Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers
    • Castéra, L., Bernard, P.H., Le Bail, B., et al. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther 33 (2011), 455–465.
    • (2011) Aliment Pharmacol Ther , vol.33 , pp. 455-465
    • Castéra, L.1    Bernard, P.H.2    Le Bail, B.3
  • 51
    • 12344309018 scopus 로고    scopus 로고
    • Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
    • Castéra, L., Vergniol, J., Foucher, J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005), 343–350.
    • (2005) Gastroenterology , vol.128 , pp. 343-350
    • Castéra, L.1    Vergniol, J.2    Foucher, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.